Paper2014204
The role of metabolites in bioequivalency assessment. I. Linear pharmacokinetics without first-pass effect.
Chen ML and 1 other. Pharm Res, 1991. Cited by 30 papers, by iCite.
Cite this record
ConductScience Library. The role of metabolites in bioequivalency assessment. I. Linear pharmacokinetics without first-pass effect. Papers, record 2014204. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2014204
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The role of metabolites in bioequivalency assessment. I. Linear pharmacokinetics without first-pass effect.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biological Availability | Major topic |
| Pharmacokinetics | Major topic |
| Acetohexamide | |
| Adolescent | |
| Adult | |
| Allopurinol | |
| Analysis of Variance | |
| Humans | |
| Male | |
| Middle Aged | |
| Models, Biological | |
| Procainamide | |
| Sulindac |
Source PubMed
References17
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3199316 | Primary, secondary, and tertiary metabolite kinetics. | J Pharmacokinet Biopharm | 1988 | https://conductscience.org/library/papers/3199316 | PubMed |
| 2 | 799549 | Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure. | Clin Pharmacokinet | 1976 | https://conductscience.org/library/papers/799549 | PubMed |
| 3 | 6759093 | Pharmacologically active metabolites of drugs and other foreign compounds. Clinical, pharmacological, therapeutic and toxicological considerations. | Drugs | 1982 | https://conductscience.org/library/papers/6759093 | PubMed |
| 4 | 3663884 | Prediction of steady-state bioequivalence relationships using single dose data I-linear kinetics. | Biopharm Drug Dispos | 1987 | https://conductscience.org/library/papers/3663884 | PubMed |
| 5 | 546862 | Determination of sulindac and its metabolites in serum by high-performance liquid chromatography. | J Chromatogr | 1979 | https://conductscience.org/library/papers/546862 | PubMed |
| 6 | 7285558 | Conversational SAAM--an interactive program for kinetic analysis of biological systems. | Comput Programs Biomed | 1981 | https://conductscience.org/library/papers/7285558 | PubMed |
| 7 | 3450848 | A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. | J Pharmacokinet Biopharm | 1987 | https://conductscience.org/library/papers/3450848 | PubMed |
| 8 | 458558 | Clinical pharmacokinetics of procainamide infusions in relation to acetylator phenotype. | J Pharmacokinet Biopharm | 1979 | https://conductscience.org/library/papers/458558 | PubMed |
| 9 | 6174262 | N-Acetylprocainamide kinetics after single and repeated oral doses. | Clin Pharmacol Ther | 1982 | https://conductscience.org/library/papers/6174262 | PubMed |
| 10 | 3693579 | Controversy. II: Bioequivalence as an indicator of therapeutic equivalence: modeling the theoretic influence of bioinequivalence on single-dose drug effect. | J Clin Pharmacol | 1987 | https://conductscience.org/library/papers/3693579 | PubMed |
| 11 | 762214 | High-performance liquid chromatographic assay for allopurinol and oxipurinol in human plasma. | J Chromatogr | 1979 | https://conductscience.org/library/papers/762214 | PubMed |
| 12 | 7299655 | High-performance liquid chromatographic assay of tolbutamide and carboxytolbutamide in human plasma. | J Pharm Sci | 1981 | https://conductscience.org/library/papers/7299655 | PubMed |
| 13 | 7048351 | Drug metabolite kinetics. | Pharmacol Ther | 1981 | https://conductscience.org/library/papers/7048351 | PubMed |
| 14 | 3626003 | Generic drugs and the prescribing physician. | JAMA | 1987 | https://conductscience.org/library/papers/3626003 | PubMed |
| 15 | 6362950 | First-pass elimination. Basic concepts and clinical consequences. | Clin Pharmacokinet | 1984 | https://conductscience.org/library/papers/6362950 | PubMed |
| 16 | 6157019 | Determination of procainamide and N-acetylprocainamide in biological fluids by high-pressure liquid chromatography. | J Pharm Sci | 1980 | https://conductscience.org/library/papers/6157019 | PubMed |
| 17 | 14098474 | EXCRETION AND THE ACCRUAL OF DRUG METABOLITES. | Nature | 1963 | https://conductscience.org/library/papers/14098474 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41350955 | Utilizing Physiologically Based Pharmacokinetic Modeling and Virtual Simulation for Simvastatin Tablets to Evaluate the Sensitivity of Using Parent vs Metabolite as Analyte on Bioequivalence Assessment. | AAPS J | 2025 | https://conductscience.org/library/papers/41350955 | PubMed |
| 20372987 | Physiological modeling to understand the impact of enzymes and transporters on drug and metabolite data and bioavailability estimates. | Pharm Res | 2010 | https://conductscience.org/library/papers/20372987 | PubMed |
| 18956142 | Equivalence-by-design: targeting in vivo drug delivery profile. | Pharm Res | 2008 | https://conductscience.org/library/papers/18956142 | PubMed |
| 18551249 | Bioavailability and bioequivalence: focus on physiological factors and variability. | Pharm Res | 2008 | https://conductscience.org/library/papers/18551249 | PubMed |
| 18349286 | Comparative bioavailability of sulindac in capsule and tablet formulations. | Cancer Epidemiol Biomarkers Prev | 2008 | https://conductscience.org/library/papers/18349286 | PubMed |
| 15244496 | Metabolites and bioequivalence: past and present. | Clin Pharmacokinet | 2004 | https://conductscience.org/library/papers/15244496 | PubMed |
| 9358562 | The pharmacokinetics of topotecan and its carboxylate form following separate intravenous administration to the dog. | Pharm Res | 1997 | https://conductscience.org/library/papers/9358562 | PubMed |
| 8481628 | Bioequivalence of allopurinol preparations: to be assessed by the parent drug or the active metabolite? | Clin Investig | 1993 | https://conductscience.org/library/papers/8481628 | PubMed |
| 7479556 | The role of metabolites in bioequivalency assessment. II. Drugs with linear pharmacokinetics and first-pass effect. | Pharm Res | 1995 | https://conductscience.org/library/papers/7479556 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2014204
GET https://conductscience.org/api/papers/v1/2014204/authors